| 000 | 01085 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515160746.0 | ||
| 264 | 0 | _c20090312 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e318198e177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLang, Anthony E | |
| 245 | 0 | 0 |
_aWhen and how should treatment be started in Parkinson disease? _h[electronic resource] |
| 260 |
_bNeurology _cFeb 2009 |
||
| 300 |
_aS39-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBasal Ganglia _xdrug effects |
| 650 | 0 | 4 |
_aDopamine Agonists _xadministration & dosage |
| 650 | 0 | 4 |
_aDyskinesias _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 773 | 0 |
_tNeurology _gvol. 72 _gno. 7 Suppl _gp. S39-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e318198e177 _zAvailable from publisher's website |
| 999 |
_c18664260 _d18664260 |
||